MedTrace Logo

A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy

NCT03415152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2020-10-12

Study results available
· View outcomes & findings →

Summary

A prospective observational program using digital technology tools to enhance patient adherence to Omacor therapy

Conditions

  • History of Myocardial Infarction
  • Hypertriglyceridemia

Interventions

DRUG

Omacor (Omega-3-acid ethyl esters)

Observational study without intervention, Omacor is prescribed in routine manner in accordance with clinical practice and the valid Instruction for Medical Use regarding the dose, duration of therapy, patient population, and therapeutic indication.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-24
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03415152 on ClinicalTrials.gov